ArticleBritish journal of pharmacology2006

A new benzoxazine compound blocks KATP channels in pancreatic beta cells: molecular basis for tissue selectivity in vitro and hypoglycaemic action in vivo.

J-F Rolland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.